Document is current
Any future updates will be listed below
-
Authors
Weiss, Caroline A. M. https://orcid.org/0009-0003-7080-619X
Brown, Lauryn A.
Miranda, Lucas
Pellizzoni, Paolo
Steigerwald, Sophia https://orcid.org/0000-0002-7513-1131
Remmert, Kirsten https://orcid.org/0009-0004-0668-4164
Hernandez, Jonathan M.
Borgwardt, Karsten
Kleiner, David E.
Ben-Moshe, Shani
Rosenberger, Florian A. https://orcid.org/0000-0003-4604-6170
Porat-Shliom, Natalie https://orcid.org/0000-0003-2676-8483
Mann, Matthias https://orcid.org/0000-0003-1292-4799
-
Funding
Funding for this research was provided by:
Max-Planck-Gesellschaft
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1ZIABC011828)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1ZIABC011828)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1ZIABC011828)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1ZIABC011828)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1ZIABC011828)
European Molecular Biology Organization (ALTF 399-2021)
- License Information
-
More Information
Article History
Received: 13 April 2025
Accepted: 8 January 2026
First Online: 20 February 2026
Competing interests
: M.M. is an indirect investor in Evosep and OmicVision Biosciences. K.B. is co-founder and scientific advisor of Computomics GmbH, Tübingen, Germany. The other authors declare no competing interests.
